OrbiMed’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $95.2M | Sell |
|
|||||
|
2023
Q1 | $162M | Sell |
|
|||||
|
2022
Q4 | $186M | Hold |
|
|||||
|
2022
Q3 | $184K | Buy |
|
|||||
|
2022
Q2 | $194K | Sell |
|
|||||
|
2022
Q1 | $190M | Sell |
|
|||||
|
2021
Q4 | $271M | Sell |
|
|||||
|
2021
Q3 | $267M | Hold |
|
|||||
|
2021
Q2 | $302M | Hold |
|
|||||
|
2021
Q1 | $285M | Buy |
|
|||||
|
2020
Q4 | $220M | Hold |
|
|||||
|
2020
Q3 | $214M | Buy |
|
|||||
|
2020
Q2 | $169M | Buy |
|
|||||
|
2020
Q1 | $138M | Buy |
|
|||||
|
2019
Q4 | $109M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $61M | Buy |
|
|||||
|
2019
Q1 | $57M | Buy |
|
|||||
|
2018
Q4 | $26.3M | Sell |
|
|||||
|
2018
Q3 | $126M | Sell |
|
|||||
|
2018
Q2 | $132M | Sell |
|
|||||
|
2018
Q1 | $232M | Buy |
|
|||||
|
2017
Q4 | $42.2M | Sell |
|
|||||
|
2017
Q3 | $55.8M | Hold |
|
|||||
|
2017
Q2 | $48.7M | Sell |
|
|||||
|
2017
Q1 | $104M | Buy |
|
|||||
|
2016
Q4 | $87.3M | Sell |
|
|||||
|
2016
Q3 | $118M | Sell |
|
|||||
|
2016
Q2 | $372M | Sell |
|
|||||
|
2016
Q1 | $487M | Sell |
|
|||||
|
2015
Q4 | $577M | Sell |
|
|||||
|
2015
Q3 | $513M | Buy |
|
|||||
|
2015
Q2 | $516M | Sell |
|
|||||
|
2015
Q1 | $573M | Buy |
|
|||||
|
2014
Q4 | $454M | Buy |
|
|||||
|
2014
Q3 | $373M | Buy |
|
|||||
|
2014
Q2 | $349M | Buy |
|
|||||
|
2014
Q1 | $310M | Buy |
|
|||||
|
2013
Q4 | $290M | Buy |
|
|||||
|
2013
Q3 | $241M | Buy |
|
|||||
|
2013
Q2 | $148M | Buy |
|